SUMO2/3 Rekombinanter Antikörper
SUMO2/3 Rekombinant Antikörper für IF/ICC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
241156E1
Kat-Nr. : 84017-5-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
84017-5-PBS bindet in IF/ICC, Indirect ELISA SUMO2/3 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | SUMO2/3 fusion protein Ag1135 |
| Vollständiger Name | SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae) |
| Berechnetes Molekulargewicht | 12 kDa |
| GenBank-Zugangsnummer | BC008420 |
| Gene symbol | SUMO3 |
| Gene ID (NCBI) | 6612 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Ubiquitin is most famous for its function in targeting proteins for degradation by the 26S proteasome, ubiquitin needs to be attached to a substrate in chains (polyubiquitylation) before being recognized by proteasome. Similarly, SUMO (small ubiquitin-related modifier) can be linked to substrates in chains (polysumoylation), SUMO modification has been implicated in many important cellular processes including the control of genome stability, signal transduction, targeting to and formation of nuclear compartments, cell cycle and meiosis. There are 4 confirmed SUMO isoforms in human, SUMO-1, SUMO-2, SUMO-3 and SUMO-4. SUMO-2 and SUMO-3 are nearly identical but are distinct from SUMO-1. SUMO2/3 conjugation was recently widely involved in neuroprotective activities. A substitution (M55V) of SUMO4 was strongly associated with the pathogenesis of type 1 diabetes (T1D) involving NF kappa B related mechanisms.







